Harm Reduction Essentials

Dosage awareness, substance testing, drug interactions, contraindications, and essential safety practices.

Harm Reduction Essentials

Harm reduction is not about encouraging use. It’s about recognizing that people will make their own choices, and those choices should be as informed and safe as possible. This guide covers the non-negotiables.

Dosage Awareness

The most common cause of unexpectedly intense or difficult experiences is simply taking too much. Potency varies enormously — especially with natural substances like mushrooms and cactus.

Psilocybin Mushrooms

Dose LevelDried MushroomsTypical Experience
Microdose0.05–0.3 gSub-perceptual
Mini / Museum0.5–1.5 gMild perceptual changes, sociable
Moderate1.5–3 gFull psychedelic experience
Strong3–5 gIntense, immersive experience
Heroic (term from McKenna)5+ gOverwhelming, ego dissolution likely

Critical warning: Mushroom potency varies by species, batch, growing conditions, and even individual mushrooms within the same batch. Psilocybe cyanescens can be 2–3 times as potent as Psilocybe cubensis. Powdered or chocolate-bar products are notoriously inconsistent. Always start lower than you think.

LSD

Dose LevelMicrogramsTypical Experience
Microdose5–20 µgSub-perceptual
Light25–75 µgMild, functional alteration
Moderate75–150 µgFull psychedelic experience
Strong150–250 µgIntense, long duration
Very strong250+ µgOverwhelming for most

LSD on blotter paper is often misrepresented. A tab sold as “250 µg” is frequently 80–120 µg. But occasionally it’s accurately dosed or even overdosed. You can’t know without lab testing.

MDMA

Dose LevelMilligramsTypical ExperienceDuration
Threshold30–50 mgMild stimulation, light mood lift3–5 hours
Light50–75 mgClear euphoria, increased sociability3–5 hours
Common75–125 mgFull empathogenic effect4–6 hours
Strong125–200 mgIntense, potentially overwhelming5–7 hours
Heavy200+ mgHigh neurotoxicity and hyperthermia risk6–8 hours

MDMA-specific risks:

  • Neurotoxicity: High or frequent doses damage serotonin axons. The “three-month rule” — spacing rolls at least three months apart — is the harm reduction standard for protecting your brain and preserving the experience.
  • Hyperthermia: MDMA raises body temperature. Dancing in hot environments without cooling breaks has caused fatal heatstroke. Take breaks, seek shade or airflow, and monitor yourself and friends.
  • Hydration balance: Dehydration is dangerous, but overhydration (hyponatremia) has also killed MDMA users. Sip water normally — about 250–500 ml per hour of activity — not liters at once.
  • Adulteration: MDMA is one of the most commonly substituted substances on the market. Methamphetamine, cathinones (“bath salts”), and PMA/PMMA have all been sold as MDMA. Reagent testing is essential.
  • SSRI blunting and danger: SSRIs significantly blunt MDMA’s effects and raise serotonin syndrome risk. Do not combine.

DMT

RouteDoseTypical ExperienceDuration
Vaporized10–30 mgBreakthrough at higher end; intense geometric visuals5–15 minutes
Vaporized (breakthrough)30–50 mgComplete dissolution of ordinary reality10–20 minutes
Oral (ayahuasca)35–100 mg DMT + MAOIExtended visionary journey with body purging4–8 hours

DMT-specific risks:

  • Intensity/brevity: DMT’s brevity is not the same as gentleness. A vaporized DMT breakthrough can be more existentially overwhelming than a 6-hour psilocybin journey. The short duration means there’s little time to settle in — you are launched.
  • MAOI interactions (ayahuasca context): Oral DMT requires an MAOI to become active. This creates serious dietary and medication restrictions. Foods high in tyramine (aged cheeses, cured meats, fermented products) can cause hypertensive crisis. Pharmaceutical MAOIs, SSRIs, and many other medications are dangerously contraindicated. Ayahuasca should never be combined with other serotonergic drugs.
  • Physical safety: The vaporized route produces near-immediate incapacitation. A sitter is essential to protect you from falling, dropping the pipe, or injuring yourself.

Mescaline

Dose LevelMilligrams (pure)Dried Peyote ButtonsTypical ExperienceDuration
Threshold50–100 mg1–2 buttonsMild stimulation, color enhancement8–12 hours
Light100–200 mg3–5 buttonsClear psychedelic effects, gentle mood lift10–14 hours
Moderate200–400 mg5–10 buttonsFull immersive experience12–16 hours
Strong400–600 mg10+ buttonsIntense, long-lasting visionary state14–18 hours

Mescaline-specific risks:

  • Duration: Mescaline lasts significantly longer than psilocybin or MDMA. A moderate dose can keep you actively tripping for 12–16 hours. Plan your setting, obligations, and recovery time accordingly.
  • Cactus potency variability: Peyote, San Pedro, and Peruvian torch cacti vary enormously in mescaline content by species, growing conditions, and preparation method. Dosing by “buttons” or grams of dried cactus is highly approximate. Start with less and wait.
  • Nausea and body load: Mescaline commonly causes significant nausea, especially with cactus preparations. The purge is sometimes considered part of the experience, but it can be physically taxing.
  • Sustainability and ethics: Peyote is endangered in the wild. Harvesting wild peyote causes ecological and cultural harm. San Pedro and Peruvian torch are more sustainable alternatives, but respect for source and preparation matters.

2C-B

Dose LevelMilligramsTypical ExperienceDuration
Threshold2–5 mgSubtle color enhancement, light mood lift2–4 hours
Light5–15 mgClear psychedelic effects, sociable, tactile3–5 hours
Moderate15–25 mgFull experience, strong visuals, body euphoria4–6 hours
Strong25–40 mgIntense, potentially overwhelming5–8 hours
Heavy40+ mgVery high risk of confusion, anxiety, physical distress6–10 hours

2C-B-specific risks:

  • Steep dose-response curve: 2C-B is famously nonlinear. The difference between 15 mg and 25 mg can be the difference between a pleasant evening and an overwhelming experience. Redosing is particularly risky because the curve is unpredictable.
  • Frequent mis-selling and substitution: 2C-B is less common than other substances and is sometimes sold as MDMA, ecstasy, or mixed into powders without disclosure. NBOMe compounds have also been sold as 2C-B. Reagent testing is critical — Marquis and Mecke reagents help distinguish 2C-B from dangerous substitutes.
  • Body load: At higher doses, 2C-B can produce significant muscle tension, gastrointestinal distress, and vasoconstriction. These physical symptoms can amplify anxiety during the experience.

Substance Testing

Reagent Kits

Reagent testing uses liquid chemicals that change color when exposed to specific substances. It’s not lab-grade identification, but it catches many dangerous adulterants.

Where to get kits:

What reagents test for:

  • Ehrlich reagent: Turns purple in the presence of indole alkaloids (psilocybin, LSD, DMT). A necessary first step — if Ehrlich doesn’t react, you don’t have what you think you have.
  • Marquis reagent: Screens for MDMA, amphetamines, and NBOMe compounds (dangerous LSD mimics that have caused deaths)
  • Mandelin / Mecke: Additional screens for adulterants and help distinguish 2C-B from substituted cathinones or NBOMes

Fentanyl Test Strips

Fentanyl is increasingly found in pressed pills and powders of all kinds. Fentanyl test strips are inexpensive and widely available from DanceSafe and harm reduction organizations.

How to use: Dissolve a small amount of your substance in water, dip the strip, read the result. Follow the specific instructions for your strip — some require dilution ratios.

What Testing Cannot Catch

  • Exact potency
  • All possible adulterants
  • Contaminants like mold or bacteria (especially with mushrooms)

Testing reduces risk. It does not eliminate it.

Critical Drug Interactions

SSRIs, SNRIs, and Serotonin Syndrome

Selective serotonin reuptake inhibitors (e.g., sertraline/Zoloft, fluoxetine/Prozac, escitalopram/Lexapro) and serotonin-norepinephrine reuptake inhibitors (e.g., venlafaxine/Effexor, duloxetine/Cymbalta) increase serotonin levels in the brain. Psychedelics and MDMA also act on serotonin pathways.

The risk: Combining can cause serotonin syndrome, a potentially life-threatening condition characterized by agitation, confusion, rapid heart rate, high blood pressure, dilated pupils, loss of muscle coordination, heavy sweating, diarrhea, and in severe cases, seizures or death.

Practical reality: Serotonin syndrome from SSRI + classical psychedelic is relatively rare but documented. SSRI + MDMA is higher risk. More commonly, SSRIs significantly blunt the effects of psychedelics, leading people to take higher doses and increasing risk.

The only safe approach: Discuss with your prescribing physician. Do not stop psychiatric medications suddenly — withdrawal can be severe. See Talking to Your Doctor.

MAOIs

Monoamine oxidase inhibitors (e.g., phenelzine/Nardil, tranylcypromine/Parnate, and the herbal supplement syrian rue) are extremely dangerous to combine with psychedelics, especially DMT/ayahuasca. This combination can cause fatal serotonin syndrome or hypertensive crisis.

Rule: If you take an MAOI, do not use psychedelics without explicit medical guidance. Period.

Lithium

Lithium (used for bipolar disorder) combined with LSD or psilocybin carries a documented risk of seizures. This is not theoretical — cases have been reported in medical literature.

Rule: If you take lithium, psychedelics are contraindicated.

Tramadol

Tramadol has SNRI properties in addition to its opioid effects. Combining with psychedelics or MDMA increases serotonin syndrome risk.

Stimulants

Combining psychedelics with cocaine, amphetamines, or MDMA (“candyflipping,” etc.) strains the cardiovascular system and increases anxiety, paranoia, and overheating risk. The combinations are unpredictable and generally discouraged by harm reduction communities.

Medical Contraindications

Mental Health

  • Personal or family history of psychosis, schizophrenia, or schizoaffective disorder: Psychedelics can trigger or accelerate onset of psychotic disorders. The risk is considered significant enough that most clinical trials exclude these individuals.
  • Bipolar I disorder: Manic episodes can be triggered. Lithium interaction adds seizure risk.
  • Bipolar II: Lower but not absent risk. Proceed only with psychiatric oversight.
  • Borderline personality disorder: Mixed evidence; some clinicians report benefits, others report destabilization.
  • Active suicidal ideation with intent: Not appropriate for an unsupervised psychedelic experience.

Physical Health

  • Cardiovascular disease: Psychedelics activate the 5-HT2B receptor, which has been associated with cardiac valve issues in chronic use. A single session is likely low risk, but anyone with significant heart disease should consult a cardiologist.
  • Uncontrolled hypertension: Risk of dangerous blood pressure spikes.
  • Pregnancy: Insufficient safety data. Not recommended.
  • Epilepsy or seizure disorders: Increased risk, especially with lithium or high doses.

Environmental Safety

Never Dose Alone at High Doses

If you’re taking a moderate or strong dose, have a sober sitter present. If you absolutely must be alone (not recommended), ensure a sober person knows where you are, what you took, and when to expect contact.

Hydration and Temperature

  • Drink water throughout the experience. Dehydration is common and worsens physical discomfort.
  • Be aware of overheating, especially in warm environments or when combining with stimulants.
  • Don’t overhydrate to the point of hyponatremia. Normal drinking is fine; don’t force liters of water.

Psychedelics are illegal in most jurisdictions. Be aware of:

  • Your local laws
  • The legal risks of possession
  • That seeking medical help in an emergency is always the right choice, regardless of legal status. Good Samaritan laws may offer some protection, but they vary by location.

Sources